Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Athreya S Reddy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Diagnostics (Basel, Switzerland)|June 27, 2024
A Machine Learning Model for the Prediction of COVID-19 Severity Using RNA-Seq, Clinical, and Co-Morbidity DataSahil Sethi, Sushil Shakyawar, Athreya S Reddy, et al.
Journal of Autoimmunity|October 17, 2022
Mutations in the monkeypox virus replication complex: Potential contributing factors to the 2022 outbreakSaathvik R Kannan, Shrikesh Sachdev, Athreya S Reddy, et al.
Expert Opinion on Investigational Drugs|January 18, 2024
Islatravir: evaluation of clinical development for HIV and HBVSamuel W Gillespie, Athreya S Reddy, Dana M Burris, et al.
Expert Opinion on Therapeutic Targets|June 27, 2023
Potential therapeutic targets for Mpox: the evidence to dateSiddappa N Byrareddy, Kalicharan Sharma, Shrikesh Sachdev, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Diagnostics (Basel, Switzerland)|June 27, 2024
A Machine Learning Model for the Prediction of COVID-19 Severity Using RNA-Seq, Clinical, and Co-Morbidity DataSahil Sethi, Sushil Shakyawar, Athreya S Reddy, et al.
Journal of Autoimmunity|October 17, 2022
Mutations in the monkeypox virus replication complex: Potential contributing factors to the 2022 outbreakSaathvik R Kannan, Shrikesh Sachdev, Athreya S Reddy, et al.
Expert Opinion on Investigational Drugs|January 18, 2024
Islatravir: evaluation of clinical development for HIV and HBVSamuel W Gillespie, Athreya S Reddy, Dana M Burris, et al.
Expert Opinion on Therapeutic Targets|June 27, 2023
Potential therapeutic targets for Mpox: the evidence to dateSiddappa N Byrareddy, Kalicharan Sharma, Shrikesh Sachdev, et al.
Pageof 1